Ignite Creation Date:
2025-12-25 @ 1:46 AM
Ignite Modification Date:
2026-01-07 @ 12:41 AM
Study NCT ID:
NCT03129594
Status:
COMPLETED
Last Update Posted:
2017-10-04
First Post:
2017-04-23
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Plasma Glucagon-like Peptide-1 Levels and Acute Myocardial Infarction
Sponsor:
Chinese PLA General Hospital
Organization:
Study Overview
Official Title:
Prognostic Value of Plasma Glucagon-like Peptide-1 Levels in Acute Myocardial Infarction
Status:
COMPLETED
Status Verified Date:
2017-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
GLP-1(9-36) amide and (9-37), which was previously thought to be the inactive metabolite of GLP-1, also exerts cardioprotective effects. Direct administration of GLP-1(9-36) during reperfusion reduced ischaemic damage in isolated hearts and increased cGMP release, vasodilatation and coronary flow in AMI mouse model, one may speculate that total GLP-1 level may associate with adverse cardiovascular events in AMI patients, the hypothesis is therefore tested in this study.
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: